Based on the aforementioned results, we speculate changes of FTO and YTHDF1 expression may promote PAH through up-regulating the m6A methylation and facilitating mRNA m6A translation of multiple molecular function, biological process or KEGG pathway relative to PAH. The gene discussed is FTO; the disease is pulmonary arterial hypertension.